Join to View Full Profile
3243 E Murdock StSuite 300Wichita, KS 67208
Phone+1 316-262-4467
Fax+1 316-681-2567
Dr. Moore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Joseph Moore, MD is an Oncology specialist located in Wichita, KS. He completed his education at the University of Kansas School of Medicine, followed by a residency in Internal Medicine at the University of Texas Southwestern Medical Center and then a fellowship in Hematology and Medical Oncology at the University of Texas Health Science Center at Houston/M D Anderson Cancer Center. Dr. Moore currently works as a Staff Physician at the Cancer Center of Kansas, preceded by roles as a Fellow at the University of Texas M.D. Anderson Cancer Center and an Internal Medicine Physician at the University of Texas Southwestern Medical Center. He has authored multiple publications, showing particular interest in the field of testicular cancer, with his work being cited multiple times by other publications.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2018 - 2021
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2015 - 2018
University of Kansas School of MedicineClass of 2015
Certifications & Licensure
KS State Medical License 2021 - 2025
TX State Medical License 2016 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Cephalexin-induced haemolytic anaemia: a rare cause of acute renal failure requiring haemodialysis.Payton Markley, Joseph Moore, Salam Kadhem, Sara Winchester, Aaron Clawson
BMJ Case Reports. 2025-04-22 - Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-W...Khalil Choucair, Seth J Page, Bassam I Mattar, Christopher S Dakhil, Nassim H Nabbout
Clinical Breast Cancer. 2023-02-01 - 6 citationsPredictive capacity of a miRNA panel in identifying teratoma in post-chemotherapy consolidation surgeries.Joseph A Moore, Michael J Lehner, Simone Anfossi, Saumil Datar, Rebecca S Tidwell
BJUI Compass. 2023-01-01
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
